Efficacy and Safety of 7 Versus 14 Days of Antibiotic Treatment for Pseudomonas Aeruginosa Bacteraemia

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
Phase IV, open-labeled, randomized and multicenter clinical trial to demonstrate the superiority of antibiotics with authorized indication for 7 days versus 14 days in the treatment of bloodstream infections produced by P. aeruginosa (BSI-PA).
Epistemonikos ID: 6733e241788d49feb537039fefa7a396d7669b5c
First added on: May 10, 2024